Elevated immunoreactivity of RANTES and CCR1 correlate with the severity of stages and dysmenorrhea in women with deep infiltrating endometriosis

Acta Histochemica

Volumn 115, Issue 5, 2013, Pages 434-439

  Yang, Yanfeng ^a   Zhang, Xinmei ^a   Zhou, Caiyun ^a   Huang, Xiufeng ^a   Lin, Jun ^a   Xu, Hong ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

CCR1; Deep infiltrating endometriosis; Dysmenorrhea; Ectopic endometrium; ER ; ER ; RANTES

Indexed keywords

CHEMOKINE RECEPTOR CCR1; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; RANTES;

ADULT; ARTICLE; CLINICAL ARTICLE; DEEP INFILTRATING ENDOMETRIOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DYSMENORRHEA; ENDOMETRIOSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; MENSTRUAL CYCLE; MOLECULAR PATHOLOGY; PROTEIN LOCALIZATION;

ADULT; BIOLOGICAL MARKERS; CELL NUCLEUS; CHEMOKINE CCL5; CYTOPLASM; DYSMENORRHEA; ENDOMETRIOSIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; RECEPTORS, CCR1; YOUNG ADULT;

EID: 84879845730     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2012.10.006     Document Type: Article

References (27)

1. Agic A., Xu H., Rehbein M., Wolfler M.M., Ebert A.D., Hornung D. Cognate chemokine receptor 1 messenger ribonucleic acid expression in peripheral blood as a diagnostic test for endometriosis. Fertil Steril 2007, 87:982-984.
2. Bedaiwy M.A., Casper R.F. Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain. Fertil Steril 2006, 86:220-222.
3. Brandenberger A.W., Lebovic D.I., Tee M.K., Ryan I.P., Tseng J.F., Jaffe R.B., et al. Oestrogen receptor (ER)-alpha and ER-beta isoforms in normal endometrial and endometriosis-derived stromal cells. Mol Hum Reprod 1999, 5:651-655.
4. Bukulmez O., Hardy D.B., Carr B.R., Word R.A., Mendelson C.R. Inflammatory status influences aromatase and steroid receptor expression in endometriosis. Endocrinology 2008, 149:1190-1204.
5. Chapron C., Fauconnier A., Dubuisson J.B., Barakat H., Vieira M., Breart G. Deep infiltrating endometriosis: relation between severity of dysmenorrhoea and extent of disease. Hum Reprod 2003, 18:760-766.
6. Chapron C., Lafay-Pillet M.C., Monceau E., Borghese B., Ngo C., Souza C., et al. Questioning patients about their adolescent history can identify markers associated with deep infiltrating endometriosis. Fertil Steril 2011, 95:877-881.
7. Deshpande R., Khalili H., Pergolizzi R.G., Michael S.D., Chang M.D. Estradiol down-regulates LPS-induced cytokine production and NFκB activation in murine macrophages. Am J Reprod Immunol 1997, 38:46-54.
8. Dominguez F., Galan A., Martin J.J., Remohi J., Pellicer A., Simon C. Hormonal and embryonic regulation of chemokine receptors CXCR1, CXCR4, CCR5 and CCR2B in the human endometrium and the human blastocyst. Mol Hum Reprod 2003, 9:189-198.
9. Fauconnier A., Chapron C., Dubuisson J., Bieira M., Dousset B., Breart G. Relation between pain symptoms and the anatomic location of deep infiltrating endometriosis. Fertil Steril 2002, 78:719-726.
10. Haas D., Chvatal R., Habelsberger A., Wurm P., Schimetta W., Oppelt P. Comparison of revised American Fertility Society and ENZIAN staging: a critical evaluation of classifications of endometriosis on the basis of our patient population. Fertil Steril 2011, 95:1574-1578.
11. Halis G., Mechsner S., Ebert A.D. The diagnosis and treatment of deep infiltrating endometriosis. Dtsch Arztebl Int 2010, 107:446-455. [quiz 456].
12. Harada T., Momoeda M., Taketani Y., Hoshiai H., Terakawa N. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial. Fertil Steril 2008, 90:1583-1588.
13. Horuk R. Molecular properties of the chemokine receptor family. Trends Pharmacol Sci 1994, 15:159-165.
14. Kyama C.M., Overbergh L., Mihalyi A., Meuleman C., Mwenda J.M., Mathieu C., et al. Endometrial and peritoneal expression of aromatase, cytokines, and adhesion factors in women with endometriosis. Fertil Steril 2008, 89:301-310.
15. Lebovic D.I., Chao V.A., Martini R. IL-1beta induction of RANTES (regulated upon activation, normal T cell expressed and secreted) chemokine gene expression in endometriotic stromal cells depends on a nuclear factor-kappaB site in the proximal promoter. J Clin Endocrinol Metab 2001, 86:4759-4764.
16. Lebre M.C., Vergunst C.E., Choi I.Y., Aarrass S., Oliveira A.S., Wyant T., et al. Why CCR2 and CCR5 blockade failed and why CCR1 blockade might still be effective in the treatment of rheumatoid arthritis. PLoS One 2011, 6(7):e21772.
17. Leyendecker G., Kunz G., Noe M., Herbertz M., Mall G. Endometriosis: a dysfunction and disease of the archimetra. Hum Reprod Update 1998, 4:752-762.
18. Matsuzaki S., Murakami T., Uehara S., Canis M., Sasano H., Okamura K. Expression of estrogen receptor alpha and beta in peritoneal and ovarian endometriosis. Fertil Steril 2001, 75:1198-1205.
19. Peveler R., Edwards J., Daddow J., Thomas E. Psychosocial factors and chronic pelvic pain: a comparison of women with endometriosis and with unexplained pain. J Psychosom Res 1996, 40:305-315.
20. Ray P., Ghosh S.K., Zhang D.H., Ray A. Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor. FEBS Lett 1997, 409:79-85.
21. Repeke C.E., Ferreira S.B., Claudino M., Silveira E.M., de Assis G.F., Avila-Campos M.J., et al. Evidences of the cooperative role of the chemokines CCL3, CCL4 and CCL5 and its receptors CCR1+ and CCR5+ in RANKL+ cell migration throughout experimental periodontitis in mice. Bone 2010, 46(4):1122-1131.
22. Rot A., von Andrian U.H. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 2004, 22:891-928.
23. The ESHRE Capri Workshop Group Noncontraceptive health benefits of combined oral contraception. Hum Reprod Update 2005, 11:513-525.
24. Tuttlies F., Keckstein J., Ulrich U., Possover M., Schweppe K.W., Wustlich M., et al. ENZIAN-score, a classification of deep infiltrating endometriosis. Zentralbl Gynakol 2005, 127:275-281.
25. Wang X.Q., Yu J., Luo X.Z., Shi Y.L., Wang Y., Wang L., et al. The high level of RANTES in the ectopic milieu recruits macrophages and induces their tolerance in progression of endometriosis. J Mol Endocrinol 2010, 45:291-299.
26. Wieser F., Yu J., Park J., Gaeddert A., Cohen M., Vigne J.L., et al. A botanical extract from channel flow inhibits cell proliferation, induces apoptosis, and suppresses CCL5 in human endometriotic stromal cells. Biol Reprod 2009, 81:371-377.
27. Yu J., Wang Y., Zhou W.H., Wang L., He Y.Y., Li D.J. Combination of estrogen and dioxin is involved in the pathogenesis of endometriosis by promoting chemokine secretion and invasion of endometrial stromal cells. Hum Reprod 2008, 23:1614-1626.